BioDelivery Sciences International, Inc.
BDSI · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $114 | $112 | $64 | $44 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $57 | $48 | $39 | $14 |
| Inventory | $24 | $17 | $11 | $5 |
| Other Curr. Assets | $7 | $5 | $4 | $3 |
| Total Curr. Assets | $202 | $182 | $118 | $66 |
| Property Plant & Equip (Net) | $2 | $1 | $2 | $3 |
| Goodwill | $3 | $3 | $3 | $3 |
| Intangibles | $62 | $53 | $60 | $37 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $57 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $123 | $58 | $65 | $42 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $325 | $240 | $183 | $109 |
| Liabilities | – | – | – | – |
| Payables | $8 | $4 | $12 | $3 |
| Short-Term Debt | $5 | $0 | $0 | $0 |
| Tax Payable | $1 | $1 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $69 | $48 | $42 | $18 |
| Total Curr. Liab. | $82 | $53 | $54 | $22 |
| LT Debt | $54 | $78 | $59 | $52 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $1 | $6 |
| Total NC Liab. | $54 | $79 | $59 | $57 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $137 | $132 | $113 | $79 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$256 | -$341 | -$367 | -$351 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $444 | $449 | $436 | $381 |
| Total Equity | $188 | $108 | $70 | $30 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $325 | $240 | $183 | $109 |
| Net Debt | -$56 | -$33 | -$5 | $8 |